MolluDab represents a new product launch available on prescription as well as over the counter from the pharmacist.
Molluscum contagiosum is a condition which often causes distress for not only…Read more
Symetis’ Acurate™ Aortic Valve Replacement System offers a minimally invasive solution for patients suffering from aortic valve stenosis. We worked closely with the Swiss company to produce corporate and…Read more
International campaigns must communicate a simple message, but always with high impact and memorability. Following our initial concept development for this new treatment for scalp psoriasis, extensive testing was…Read more
Firmagon is the UK’s first GnRH blocker for the treatment of advanced prostate cancer and represents a significant pharmacologic advance over the current standard of care.
Following our win of…Read more
Having developed the core concept for the international launch of this novel Parkinson’s disease treatment, a complete integrated communications campaign was created. Strong branding and consistent messaging across below…Read more